Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.08 - $0.55 $2,249 - $15,464
28,118 Added 588.24%
32,898 $2,000
Q2 2023

Aug 14, 2023

BUY
$0.56 - $1.17 $1,195 - $2,497
2,135 Added 80.72%
4,780 $2,000
Q1 2023

May 09, 2023

BUY
$1.02 - $1.39 $2,697 - $3,676
2,645 New
2,645 $3,000
Q3 2022

Nov 10, 2022

BUY
$1.28 - $2.91 $19,818 - $45,055
15,483 New
15,483 $32,000
Q2 2022

Aug 15, 2022

SELL
$1.21 - $1.81 $3,656 - $5,469
-3,022 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$1.03 - $2.01 $1,377 - $2,687
1,337 Added 79.35%
3,022 $5,000
Q4 2021

Feb 14, 2022

SELL
$0.98 - $3.06 $6,039 - $18,858
-6,163 Reduced 78.53%
1,685 $2,000
Q3 2021

Nov 15, 2021

BUY
$2.79 - $4.19 $3,029 - $4,550
1,086 Added 16.06%
7,848 $23,000
Q2 2021

Aug 16, 2021

SELL
$2.8 - $3.78 $26,191 - $35,358
-9,354 Reduced 58.04%
6,762 $20,000
Q1 2021

May 17, 2021

BUY
$3.26 - $4.84 $39,879 - $59,207
12,233 Added 315.04%
16,116 $53,000
Q4 2020

Feb 16, 2021

SELL
$4.12 - $6.29 $11,198 - $17,096
-2,718 Reduced 41.18%
3,883 $16,000
Q3 2020

Nov 16, 2020

BUY
$4.82 - $8.77 $7,895 - $14,365
1,638 Added 33.0%
6,601 $36,000
Q2 2020

Aug 13, 2020

BUY
$2.83 - $6.99 $13,431 - $33,174
4,746 Added 2187.1%
4,963 $33,000
Q1 2020

May 15, 2020

SELL
$3.18 - $7.0 $34,983 - $77,007
-11,001 Reduced 98.07%
217 $0
Q4 2019

Feb 07, 2020

BUY
$3.46 - $7.7 $6,103 - $13,582
1,764 Added 18.66%
11,218 $79,000
Q3 2019

Nov 05, 2019

BUY
$2.8 - $3.99 $24,721 - $35,227
8,829 Added 1412.64%
9,454 $36,000
Q2 2019

Aug 13, 2019

SELL
$2.34 - $4.28 $7,937 - $14,517
-3,392 Reduced 84.44%
625 $2,000
Q1 2019

May 14, 2019

BUY
$3.6 - $8.75 $6,804 - $16,537
1,890 Added 88.86%
4,017 $14,000
Q4 2018

Feb 14, 2019

BUY
$6.25 - $9.2 $13,293 - $19,568
2,127 New
2,127 $16,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0

About RVL Pharmaceuticals plc


  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.